共 227 条
[1]
Javitt DC(2004)Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists Neuropsychopharmacology 29 300-307
[2]
Balla A(1991)Phencyclidine, NMDA receptor and schizophrenia Yakubutsu Seishin Kodo 11 65-69
[3]
Burch S(2004)Glutamate as a therapeutic target in psychiatric disorders Mol Psychiatry 9 984-997
[4]
Suckow R(2006)D-alanine added to antipsychotics for the treatment of schizophrenia Biol Psychiatry 59 230-234
[5]
Xie S(1989)D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics Neurosci Lett 98 91-95
[6]
Sershen H(1995)Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia Am J Psychiatry 152 1213-1215
[7]
Nishikawa T(1996)D-cycloserine added to clozapine for patients with schizophrenia Am J Psychiatry 153 1628-1630
[8]
Tanii Y(1999)A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia Biol Psychiatry 45 512-514
[9]
Umino A(1999)A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia Arch Gen Psychiatry 56 21-27
[10]
Hashimoto A(2005)A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients Psychopharmacology 179 144-150